文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

脓毒症住院合并与不合并急性肾损伤的趋势与结局:全国住院患者分析

TRENDS AND OUTCOMES IN SEPSIS HOSPITALIZATIONS WITH AND WITHOUT ACUTE KIDNEY INJURY: A NATIONWIDE INPATIENT ANALYSIS.
PubMed 文献 · Shock · 2024-06-11
一句话结论美国2010–2019年脓毒症住院患者中急性肾损伤(AKI)患病率从39.10%升至41%,而合并AKI的院内死亡率从26.30%降至16.30%。

该研究基于美国全国住院患者样本数据库,回顾性分析2010至2019年因脓毒症住院的成人(≥18岁)患者,脓毒症与AKI均按ICD-9-CM和ICD-10-CM编码定义。在3,946,048例符合纳入标准的住院中,脓毒症患者AKI患病率从2010年的39.10%上升至2019年的41%,但AKI对死亡率的影响随时间下降,合并AKI的脓毒症住院患者院内死亡率从2010年的26.30%降至2019年的16.30%。合并AKI的住院更常涉及尿路、胃肠道和心内膜炎等感染部位,大肠埃希菌、金黄色葡萄球菌、链球菌属、肠球菌属和假单胞菌属等病原体检出率更高,且中位总住院费用和住院天数均高于不合并AKI者。

要点

  • 2010–2019年美国脓毒症住院患者AKI患病率从39.10%升至41%,同期合并AKI的院内死亡率从26.30%降至16.30%。
  • 合并AKI的脓毒症住院更常涉及尿路、胃肠道和心内膜炎等感染部位。
  • 大肠埃希菌、金黄色葡萄球菌、链球菌属、肠球菌属和假单胞菌属在合并AKI的脓毒症住院中检出率更高。
  • 与不合并AKI的脓毒症住院相比,合并AKI者中位总住院费用和住院天数均更高。
  • 该研究为回顾性全国住院样本分析,脓毒症和AKI均基于ICD编码定义。

适用人群与场景

  • 2010至2019年在美国因脓毒症住院的成人(≥18岁)患者。

诊断标准与关键阈值

  • 脓毒症和AKI均使用国际疾病分类第九版临床修订本(ICD-9-CM)和第十版临床修订本(ICD-10-CM)编码定义。

研究设计与关键结果

  • 研究类型:基于美国全国住院患者样本数据库的回顾性分析;共4,258,360例结局,其中3,946,048例符合纳入标准。
  • 脓毒症住院患者AKI患病率从2010年的39.10%上升至2019年的41%。
  • 合并AKI的脓毒症住院患者院内死亡率从2010年的26.30%下降至2019年的16.30%。
  • 合并AKI的住院更常涉及尿路、胃肠道和心内膜炎等感染部位。
  • 大肠埃希菌、金黄色葡萄球菌、链球菌属、肠球菌属和假单胞菌属在合并AKI的脓毒症住院中检出率更高。
  • 与不合并AKI的脓毒症住院相比,合并AKI者中位总住院费用和住院天数均更高。

证据类型、等级与局限

  • 证据类型:基于全国代表性住院患者样本数据库的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Despite rapid advances in treatment, sepsis currently remains a major public health challenge worldwide. Over the past several years, there has been an increase in the clinical incidence of sepsis, as well as an increase in hospitalization rates, which bear the majority of the economic burden associated with sepsis. Sepsis is a public health burden due to the high fatality rates and accompanying morbidity. However, the sepsis-related mortality rates have fallen steadily over the years. One of the most common organs to fail in patients with sepsis is the kidney, and acute kidney injury (AKI) is associated with high mortality rates. This study's primary goal was to assess the impact of AKI on the evolution and outcome of hospitalization of patients with sepsis. Methods: Adults (≥18 years) hospitalized for sepsis in the United States between 2010 and 2019 were retrospectively analyzed using the nationally representative Nationwide Inpatient Sample database. Sepsis and AKI were defined using the codes of the International Classification of Diseases, Ninth Revision, Clinical Modification and the International Classification of Diseases, Tenth Revision, Clinical Modification. Results: Of the 4,258,360 outcomes, 3,946,048 met the inclusion criteria. The prevalence of AKI among sepsis inpatients increased from 39.10% in 2010 to 41% in 2019, but the impact of AKI on mortality declined over time, with in-hospital mortality from AKI among sepsis inpatients decreasing from 26.30% in 2010 to 16.30% in 2019. Hospitalizations linked to AKI were substantially more likely to involve infection sites such as the urinary tract, gastrointestinal tract, and endocarditis. Numerous pathogenic floras, including Escherichia coli , Staphylococcus aureus , Streptococcal , Enterococcus , and Pseudomonas , had greater rates among sepsis-related contacts with AKI. Furthermore, compared to hospitalization without comorbid AKI, the median total hospital charges and length of stay days for sepsis hospitalization with comorbid AKI were greater. Conclusion: With time, patients with sepsis have a higher frequency of AKI and a corresponding decline in mortality.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Li H, Yu R, Zhou Q, et al. TRENDS AND OUTCOMES IN SEPSIS HOSPITALIZATIONS WITH AND WITHOUT ACUTE KIDNEY INJURY: A NATIONWIDE INPATIENT ANALYSIS. Shock. 2024. PMID: 38888575. doi:10.1097/SHK.0000000000002386

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。